Patients with Chronic Obstructive Pulmonary Disease harbour a variation of Haemophilus species

Karen L. Osman(Defence Science and Technology Laboratory), Stephen A. Wootton(University of Southampton), Karl J. Staples(University Hospital Southampton NHS Foundation Trust), Andrew Tuck(University of Southampton), Nathalie Devos(GlaxoSmithKline (Belgium)), Anthony P. Williams(University of Southampton), Jenna Alnajar(University of Southampton), M. Wojtas(University of Southampton), Ngaire Coombs(University of Southampton), Jeanne‐Marie Devaster(GlaxoSmithKline (Belgium)), Lindsay Welch(GlaxoSmithKline (Belgium)), Christopher H. Woelk(University of Southampton), Elizabeth H. Dineen(University of California, Irvine), Rebecca A. Gladstone(Wellcome Sanger Institute), Simon Bourne(GlaxoSmithKline (Belgium)), Tim Elliott(University of Southampton), V. Kim(Temple University), S. Harden(New South Wales Department of Primary Industries), M. Caubet(GlaxoSmithKline (Belgium)), Vincent Weynants(GlaxoSmithKline (Belgium)), A. Barton(University of Southampton), Tom Wilkinson(University Hospital Southampton NHS Foundation Trust), Stuart C. Clarke(University Hospital Southampton NHS Foundation Trust), Vanessa T. Devine(University of Southampton), Sonia Schoonbroodt(University of Liège), Catherine Cohet(GlaxoSmithKline (Belgium)), Raydel Anderson(GlaxoSmithKline (Belgium)), Emmanuel Aris(GlaxoSmithKline (Belgium)), Saddie Vela(GlaxoSmithKline (Belgium)), Nicholas Williams(University of Southampton), Thierry Pascal(GlaxoSmithKline (Belgium)), Philippe Moris(GlaxoSmithKline (Belgium)), W R Ballou(GlaxoSmithKline (Belgium)), Marie-Cécile Mortier(GlaxoSmithKline (Belgium)), Mathieu Peeters(GlaxoSmithKline (Belgium)), David Cleary(University of Birmingham), K. Ostridge(GlaxoSmithKline (Belgium)), Johanna M. Jefferies(University Hospital Southampton NHS Foundation Trust)
Scientific Reports
September 27, 2018
Cited by 20


Related Papers